Stock EKZRF ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Eckert & Ziegler Strahlen- und Medizintechnik AG OTC Markets

Equities

EKZRF

DE0005659700

Delayed OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Eckert & Ziegler Strahlen- und Medizintechnik AG -.--% -.--%
06-25 German Stocks Fall Tuesday DJ
06-25 Eckert & Ziegler Unit Gets 'Encouraging' Feedback from US FDA for Lead Diagnostic MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Sales forecast by analysts have been recently revised upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 28.84 times its estimated earnings per share for the ongoing year.
  • The company's enterprise value to sales, at 3.52 times its current sales, is high.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.

Ratings chart - Surperformance

Sector: Office Equipment

1st Jan change Capi. Investor Rating ESG Refinitiv
ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG Stock Eckert & Ziegler Strahlen- und Medizintechnik AG
-.--% 1.07B -
TECAN GROUP AG Stock Tecan Group AG
-12.41% 4.33B
B
OLINK HOLDING AB Stock Olink Holding AB
+1.35% 3.15B -
JEOL LTD. Stock JEOL Ltd.
+17.42% 2.22B -
PARK SYSTEMS CORP. Stock Park Systems Corp.
+7.78% 936M -
NINGBO YONGXIN OPTICS CO.,LTD Stock Ningbo Yongxin Optics Co.,Ltd
-39.11% 928M -
MLOPTIC CORP. Stock MLOptic Corp.
-57.14% 684M -
PHENIX OPTICAL COMPANY LIMITED Stock Phenix Optical Company Limited
-28.72% 629M - -
FOCUSED PHOTONICS (HANGZHOU), INC. Stock Focused Photonics (Hangzhou), Inc.
-36.34% 614M -
SVG TECH GROUP CO.,LTD. Stock SVG Tech Group Co.,Ltd.
-35.63% 564M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. EUZ Stock
  4. EKZRF Stock
  5. Ratings Eckert & Ziegler Strahlen- und Medizintechnik AG